News
When lung cancer advances after initial lines of therapy, the treatment options dwindle. An AbbVie drug gives patients a new choice as the first FDA-approved treatment for advanced cases of non ...
Despite years of warnings and a mountain of scientific evidence linking smoking to lung cancer, there remains one confounding question: Why do some smokers never get lung cancer? It’s a puzzle ...
"Go and see your doctor if you've got anything that you're concerned about – that's what a [doctor] is for," Brian Gemmell said Getty A lung cancer patient had no respiratory symptoms before his ...
Tumor DNA in the Blood Can Predict Lung Cancer Outcome Jan. 13, 2025 — Scientists have found that a test to detect circulating tumor DNA can predict lung cancer ... Milestone in the Field of ...
AstraZeneca’s hopes of positioning its PD-L1 inhibitor Imfinzi as a post-surgery therapy for people with earlier-stage lung cancer have taken a knock, although it performed well in a bladder ...
The cancer is common in older men, and it is the second-leading cause of cancer death in American men, behind lung cancer ... to provide more successful tumor-removal surgeries for people facing ...
At the World Conference on Lung Cancer (WCLC) in San Diego, interim results from the dose optimisation part of the Ideate-Lung01 trial showed the benefit of the 12 mg/kg dose of the antibody-drug ...
The tumor microenvironment influences the metabolic ... Despite advances in drug development, some patients with non-small-cell lung cancer (NSCLC) have suboptimal responses to treatment.
Today, the American Lung Association’s LUNG FORCE initiative celebrates Lung Cancer Action Week in California, proclaimed the second week of May, uniting America to stand against lung cancer, the ...
The importance of precision therapeutics will be an overarching theme spotlighted during the upcoming 26th Annual International Lung Cancer Congress®. Developing treatment strategies to identify the ...
At the gala, she gave People a health update on her ongoing skin cancer journey. The 43-year-old stated that she went through immunotherapy recently, and her scan results show that her tumors are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results